MOTS-c Research Hub — Mitochondrial Peptide & Metabolic Studies
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino-acid mitochondrial-derived peptide widely cited in metabolic, mitochondrial and longevity research.
What this hub covers
- Mitochondrial-derived peptide (MDP) biology
- AMPK activation and downstream metabolic signalling
- Insulin sensitivity and glucose-homeostasis literature
- Comparisons to SS-31 and broader mitochondrial-targeted research
- Reconstitution and storage
MOTS-c research articles
All research →MOTS-c Benefits and Side Effects: A Research Guide
Published benefits, side effects, and mechanism review for MOTS-c — the mitochondrial-derived peptide that activates AMPK and is studied for insulin sensitivity, exercise capacity, and metabolic aging.
Read article →SS-31 Benefits and Side Effects: A Research Guide
Published benefits, side effects, and trial review for SS-31 (Elamipretide) — the cardiolipin-binding mitochondria-targeted peptide with the largest clinical dataset in the mitochondrial-research literature.
Read article →Related research hubs
Researchers studying MOTS-c commonly cross-reference these compounds.
SS-31 (also known as elamipretide / Bendavia) is a synthetic tetrapeptide that selectively binds cardiolipin on the inner mitochondrial membrane. It is widely cited in bioenergetic, cardiac and neuro-research models.
Explore hub →Epithalon (also Epitalon or Epithalone) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed from research on the pineal peptide Epithalamin. It is widely cited in telomerase-activity and longevity research.
Explore hub →MOTS-c research FAQ
- What is MOTS-c?
- MOTS-c is a 16-amino-acid peptide encoded within mitochondrial DNA and one of the most-studied mitochondrial-derived peptides (MDPs) in metabolic research.
- What signalling pathway is most cited?
- AMPK activation is the most-cited downstream pathway, with secondary effects on glucose uptake and mitochondrial biogenesis described in published cell and rodent models.
- How does MOTS-c differ from SS-31?
- MOTS-c is an endogenous MDP that acts via metabolic-signalling cascades; SS-31 (elamipretide) is a synthetic tetrapeptide that binds cardiolipin and stabilises the inner mitochondrial membrane. They are mechanistically distinct.
All content on this hub is provided strictly for laboratory research purposes. Compounds listed are not for human or veterinary consumption. See our research-use disclosure for full terms.